Tim Kaine actually said...

"the challenges associated with developing treatments and the investments we make to develop novel medicines, that is really completely a red herring with respect to Syprine."

"As much as we in politics sometimes rankle under a free press that is free and robust and challenging, we sure would not trade it for anything else."

"Thank you, Mr. Chairman."

"So big, big challenge, will not be quick, but we need not despair about the ability to move the needle the right way if we invest the right way."